NEXGEL appoints two Sequence LifeScience leaders to board; Sequence led $5.5M financing

NEXGEL, INC.

Brian J. Kieser (CEO) and Kevin M. Harris (COO) of Sequence LifeScience appointed to NEXGEL board effective May 6, 2026.
Sequence led $5.5M convertible note financing ($0.60/ share conversion, $0.80 warrant) to close Celularity acquisition.
Kieser individually issued $1M convertible note (same terms: $0.60 conversion, $0.80 warrant) on May 11, 2026.
Kieser is indirect sole owner of Sequence; Harris is COO with no equity in Sequence.

item 5.02 item 8.01 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Kevin M. Harris

Director

NXGL · NEXGEL, INC.

Effective: 2026-05-06
Filed: May 12, 2026, 4:30 PM ET

On May 6, 2026, Brian J. Kieser and Kevin M. Harris (collectively, the “ Board Appointees ”) were appointed to the board of directors

Appointed

Brian J. Kieser

Director

NXGL · NEXGEL, INC.

Effective: 2026-05-06
Filed: May 12, 2026, 4:30 PM ET

On May 6, 2026, Brian J. Kieser and Kevin M. Harris (collectively, the “ Board Appointees ”) were appointed to the board of directors

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Kevin M. Harris was appointed as Director at NEXGEL, INC..

Action: appointed
Role: Director

Exact text from the filing

On May 6, 2026, Brian J. Kieser and Kevin M. Harris (collectively, the “ Board Appointees ”) were appointed to the board of directors

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Brian J. Kieser was appointed as Director at NEXGEL, INC..

Action: appointed
Role: Director

Exact text from the filing

On May 6, 2026, Brian J. Kieser and Kevin M. Harris (collectively, the “ Board Appointees ”) were appointed to the board of directors

View on SEC.gov

NEXGEL, INC. filing history →

Source: SEC EDGAR

accession 0001493152-26-022503

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.